Pharmaids Pharmaceuticals Limited (BOM:524572)

Market Cap	1.67B
Revenue (ttm)	248.12M
Net Income (ttm)	-132.67M
Shares Out	35.27M
EPS (ttm)	-3.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,765
Average Volume	3,691
Open	47.82
Previous Close	47.59
Day's Range	47.06 - 49.30
52-Week Range	42.00 - 77.40
Beta	0.11
RSI	47.62
Earnings Date	Feb 12, 2026

About Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. The company offers pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile,pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine,2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino]thiophene-3-carbonitrile, 4-amino-2-methyl-1...

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 28
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524572

Financial Performance

In 2024, Pharmaids Pharmaceuticals's revenue was 195.14 million, an increase of 27.54% compared to the previous year's 153.00 million. Losses were -107.77 million, 35.2% more than in 2023.